Focal radiation for prostate cancer with HDR brachytherapy
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a targeted radiation treatment called HDR brachytherapy for prostate cancer that hasn't spread. It aims to treat only the cancer spots seen on MRI, which may reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a prostate cancer diagnosis confirmed by a biopsy within the last 90 days.
- An MRI must show one or more cancer spots.
- You cannot have cancer that has spread to distant parts of the body or lymph nodes, confirmed by a bone scan, CT or MRI, or a PSMA PET scan.
- Your overall health should be good enough that you can take care of yourself (ECOG score 0 or 1).
- You must be at least 40 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a combination of two radiation types—high-dose-rate brachytherapy and stereotactic body radiotherapy—to treat certain intermediate- to high-risk prostate cancers. It may help by aiming radiation closely at the prostate while also targeting the cancer from outside the body.
This study tests a new way to give high-dose radiation to prostate cancer while using an MRI to precisely target the tumor. It is for early-stage prostate cancer, and aims to reduce side effects by treating only the cancer, not the whole prostate.
This trial compares two imaging methods (CT and MRI) used to plan a type of radiation therapy for prostate cancer called high-dose-rate brachytherapy. The goal is to see if one method provides better targeting of the cancer while sparing healthy tissue.
This trial tests a focused form of radiation placed inside the prostate to treat only the cancer area in people with low-risk prostate cancer. It aims to control the cancer while limiting treatment to a smaller area.
This study tests a targeted radiation approach called high-dose-rate (HDR) brachytherapy, guided by MRI, for certain people with recurrent or higher-risk prostate cancer. It may help deliver radiation more precisely, depending on your cancer type and prior treatments.
This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.